申请人:Adir et Compagnie
公开号:US05534511A1
公开(公告)日:1996-07-09
The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or base and medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.
该发明涉及选择自式(I)的化合物:##STR1## 其中R.sub.1、R.sub.2、R.sub.3、X和n如描述中所定义,其光学异构体,以及与药学上可接受的酸或碱形成的加合盐,以及含有该化合物的药物产品,用于治疗患有与西格玛受体相关的病理的哺乳动物。